期刊
JOURNAL OF NEUROCHEMISTRY
卷 86, 期 5, 页码 1057-1071出版社
WILEY
DOI: 10.1046/j.1471-4159.2003.01942.x
关键词
activation of glia; HIV dementia; neurodegeneration; neuroprotection; nuclear factor-kappa B; tumor necrosis factor-alpha
资金
- NIA NIH HHS [R03 AG019487-01] Funding Source: Medline
- NINDS NIH HHS [R01 NS039940, R01 NS039940-02, NS 39940] Funding Source: Medline
Human immunodeficiency type-1 (HIV-1) infection is known to cause disorders of the CNS, including HIV-associated dementia (HAD). It is suspected that tumor necrosis factor-alpha (TNF-alpha) released by infected microglia and macrophages play a role in neuronal injury seen in HAD patients. Accordingly, studies suggest that the level of TNF-alpha mRNA increases with increasing severity of dementia in patients, and that inhibitors of TNF-alpha release reduces neuronal injury in murine model of HAD. However, the exact role of TNF-alpha in relation to neuronal dysfunction is a matter of ongoing debate. One school of thought hails TNF-alpha as the inducer and mediator of neurodegeneration and their evidence suggest that TNF-alpha kill neurons directly by recruiting caspases or may kill indirectly by various means. In sharp contrast to this, another concept theory envisages a role for TNF-alpha in negotiating neuroprotection during HAD. The current compilation examines these contradictory concepts, and evaluates their efficacy in the light of TNF-alpha signaling. It also attempts to elaborate the current consensus outlook of TNF-alpha's role during HAD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据